In line with a previous study (7), we also found a decrease in insulin requirement in patients with type 1 diabetes mellitus treated with DR-HC, compared to an increase in those patients maintaining conventional GC therapy. The gene discussed is INS; the disease is type 1 diabetes mellitus.